According to WSJ, Signify Health (SGFY) seeking strategic alternatives

  • August 2, 2022

POTENTIAL DEAL DETAILS

StockSignify Health, Inc.SymbolSGFY
Date Announced08/02/2022Source Wall Street Journal
TypeNews Report
Date of Confirmation: 09/05/2022Price at Confirmation: $28.77
Potential Profit: 57.13%Annualized Profit: 613.28%

Signify Health Inc. (SGFY) is working with bankers to explore strategic alternatives including a sale, according to people familiar with the matter, roughly 18 months after the healthcare-services company’s initial public offering of stock.

Update(s):

August 21, 2022: Amazon.com (AMZN) is among the bidders for healthcare company Signify Health, joining other heavy hitters vying in an auction for the home-health-services provider, according to people familiar with the matter.

September 2, 2022: Drugstore chain owner CVS Health Corp (CVSis in advanced talks to buy home-healthcare company Signify Health Inc (SGFY) for about $8 billion, according to a person familiar with the matter.

September 5, 2022: CVS Health (CVS) and Signify Health (SGFY) have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.